Anti-parasitic drug Ivermectin is no longer allowed to be prescribed to COVID-19 patients.
The South African Health Products Regulatory Authority has terminated the controlled Compassionate Use Access Programme with immediate effect, saying there’s no credible evidence it helps treat COVID-19.
The authority had allowed it’s use in January last year amid public interest and reports of illicit Ivermectin entering the market.
It said that since the programme was introduced, more evidence has emerged around the efficacy of Ivermectin.
This includes the World Health Organization issuing an advisory that only recommended Ivermectin use within the context of clinical trials.
In South Africa, no further importation of unregistered Ivermectin products will be allowed and health facilities will no longer be enabled to hold bulk stock in anticipation of prescriptions.
More Stories
Petro SA, Eskom Working On Cost Of Diesel Solution
Ramaphosa Asks Mabuza To Stay On, For now
Three SA Tourism Board Members Resign Amid Controversial R1bn Hotspur Deal
China Balloon Over U.S. Deflates Hopes For Diplomatic Thaw
Zelenskyy Meets with European Leaders
Eskom Needs More Than Money To Solve Its Problems – Analyst
SA Tourism R1bn Sponsorship Unjustified – Ramaphosa
Zuma Decries SCA Parole Ruling
Parliament Processing Key Recommendations Of State Capture Report
African Nations Commit To Ending AIDS In Children By 2030
Tourism Department Responds To Tottenham Hotspur Deal
Vulnerable South Africans Now Eligible For 5th COVID-19 Booster